JBC: A spring-loaded sensor for cholesterol in cells
Researchers at the University of New South Wales have discovered that a spring-shaped protein structure senses cholesterol in cells.Courtesy of Andrew J. Brown, University of New South Wales Although too much cholesterol is bad for your health, some cholesterol is essential. Most of the cholesterol that the human body needs is manufactured in its own cells in a synthesis process consisting of more than 20 steps. from the University of New South Wales in Sydney, Australia, published in the Journal of Biological Chemistry, explains how an enzyme responsible for one of these steps acts as a kind of thermostat that responds to and adjusts levels of cholesterol in the cell. This insight could lead to new strategies for combating high cholesterol.
Toward the middle of the assembly line of cholesterol production, an enzyme called squalene monooxygenase, or SM, carries out a slow chemical reaction that sets the pace of cholesterol production. In 2011, laboratory at UNSW discovered that when cholesterol in the cell was high, SM was destroyed and less cholesterol was produced. The new research explains how this process of sensing and destruction happens.
SM is embedded in the membrane of the cell’s endoplasmic reticulum, or ER, which is composed of fatty molecules, including cholesterol. As cholesterol in the cell increases, more and more of it is incorporated into the ER membrane.
SM contains a series of 12 amino acids that serve as a “destruction code” that tells the cell’s garbage disposal machinery to degrade the SM protein. Brown’s team showed that under typical conditions, the destruction code is hidden by being tucked away inside the ER membrane as part of a spring-shaped structure. Using experiments in cell cultures and with isolated proteins and membranes, they also showed that this spring structure could embed only in membranes that contained a low percentage of cholesterol. When the amount of cholesterol making up the membrane increased, the spring popped out, exposing the destruction code.
, a graduate student, led the new study. “When cholesterol levels are low, this destruction code is hidden in the membrane like a spring-loaded trap,” Chua said. “However, too much cholesterol (in the membrane) springs the trap, unmasking the destruction code.”
When this occurs, the cell proceeds to destroy the SM.
The researchers speculate that, because the synthesis step carried out by SM is crucial to determining the amount of cholesterol a cell produces, drugs targeting SM could be used to decrease cholesterol as an alternative to the oft-prescribed statins, which target an enzyme earlier in the cholesterol synthesis assembly line. But they also wonder whether the type of cholesterol-responsive spring they discovered might be used by other proteins involved in cholesterol metabolism to sense and adjust cholesterol levels.
“It’s perhaps stretching the bow a little too far to make a connection from our little cholesterol spring mechanism to metabolic disorders,” Brown said. “But we’ve found a fundamental cholesterol-sensing mechanism, and that’s where this work has advanced the field.”
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Guiding grocery carts to shape healthy habits
Robert “Nate” Helsley will receive the Walter A. Shaw Young Investigator in Lipid Research Award at the 2025 ASBMB Annual Meeting, April 12–15 in Chicago.
Quantifying how proteins in microbe and host interact
“To develop better vaccines, we need new methods and a better understanding of the antibody responses that develop in immune individuals,” author Johan Malmström said.
Leading the charge for gender equity
Nicole Woitowich will receive the ASBMB Emerging Leadership Award at the 2025 ASBMB Annual meeting, April 12–15 in Chicago.
CRISPR gene editing: Moving closer to home
With the first medical therapy approved, there’s a lot going on in the genome editing field, including the discovery of CRISPR-like DNA-snippers called Fanzors in an odd menagerie of eukaryotic critters.
Finding a missing piece for neurodegenerative disease research
Ursula Jakob and a team at the University of Michigan have found that the molecule polyphosphate could be what scientists call the “mystery density” inside fibrils associated with Alzheimer’s, Parkinson’s and related conditions.
From the journals: JLR
Enzymes as a therapeutic target for liver disease. Role of AMPK in chronic liver disease Zebrafish as a model for retinal dysfunction. Read about the recent JLR papers on these topics.